Advertisement
Advertisement
AZN
AstraZeneca PLC
166.79
USDSponsored
+0.81
+0.49%
Aug 24, 15:51 UTC -4
Open
AZN Earnings Reports
Positive Surprise Ratio
AZN beat 26 of 42 last estimates.
62%
Next Report
Date of Next Report
Oct 30, 2026
Estimate for Q3 26 (Revenue/ EPS)
$16.56B
/$2.71
Implied change from Q2 26 (Revenue/ EPS)
+7.64%
/+3.04%
Implied change from Q3 25 (Revenue/ EPS)
+9.00%
/+13.87%
AstraZeneca PLC earnings per share and revenue
On Jul 27, 2026, AZN reported earnings of 2.63 USD per share (EPS) for Q2 26, beating the estimate of 2.55 USD, resulting in a 3.12% surprise. Revenue reached 15.38 billion, compared to an expected 15.92 billion, with a -3.38% difference. The market reacted with a +0.22% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 2.71 USD, with revenue projected to reach 16.56 billion USD, implying an increase of 3.04% EPS, and increase of 7.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.11
Actual
$0.35
Surprise
+198.38%
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Alpha Cognition Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.40
Surprise
-0.05%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
PDS Biotechnology Corporation Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.18
Surprise
-35.75%
FAQ
What were AstraZeneca PLC's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, AstraZeneca PLC reported EPS of $2.63, beating estimates by 3.12%, and revenue of $15.38B, -3.38% below expectations.
How did the market react to AstraZeneca PLC's Q2 2026 earnings?
The stock price moved up 0.22%, changed from $169.26 before the earnings release to $169.64 the day after.
When is AstraZeneca PLC expected to report next?
The next earning report is scheduled for Oct 30, 2026.
What are the forecasts for AstraZeneca PLC's next earnings report?
Based on 6
analysts, AstraZeneca PLC is expected to report EPS of $2.71 and revenue of $16.56B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement